Regeneron Files Antitrust Lawsuit Accusing Amgen Of Engaging In A Persistent Exclusionary Campaign To Deny Patients Access To Praluent® - Antitrust, EU Competition
Late last week, Regeneron Pharmaceuticals, Inc. filed an antitrust complaint against Amgen Inc. in the U.S. District Court for the District of Delaware.